Holen Sie sich die Stockscreener-App
0.4475
9.92%
0.0404
Handel nachbörslich:
.44
-0.0075
-1.68%
Schlusskurs vom Vortag:
$0.4071
Offen:
$0.42
24-Stunden-Volumen:
1.48M
Relative Volume:
0.75
Marktkapitalisierung:
$21.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.65M
KGV:
-0.268
EPS:
-1.67
Netto-Cashflow:
$-24.14M
1W Leistung:
-2.21%
1M Leistung:
+14.39%
6M Leistung:
-76.57%
1J Leistung:
-44.86%
1-Tages-Spanne:
$0.41
$0.4525
1-Wochen-Bereich:
$0.401
$0.47
52-Wochen-Spanne:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
(408) 501-8881
Adresse
10080 N WOLFE ROAD, CUPERTINO
Vergleichen Sie RVPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.4475 | 27.68M | 0 | -37.65M | -24.14M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
Building trade automation scripts for Reviva Pharmaceuticals Holdings Inc. Equity WarrantReal Trader Watchlist with Entry Targets - Newser
Reviva Pharmaceuticals Holdings Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
How many analysts rate Reviva Pharmaceuticals Holdings Inc. as a “Buy”Discover high-impact stocks for your portfolio - Jammu Links News
Should I hold or sell Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock in 2025Track top-performing stocks in real-time - Jammu Links News
What are Reviva Pharmaceuticals Holdings Inc. company’s key revenue driversFree Investment Timing Strategies - Jammu Links News
How volatile is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock compared to the marketCapitalize on momentum-driven investment opportunities - Jammu Links News
What makes Reviva Pharmaceuticals Holdings Inc. stock price move sharplyUnprecedented profit potential - Jammu Links News
What are the latest earnings results for Reviva Pharmaceuticals Holdings Inc.Build wealth with steady, reliable stocks - Jammu Links News
How strong is Reviva Pharmaceuticals Holdings Inc. company’s balance sheetHigh-yield market plays - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. a good long term investmentCapitalize on strong market momentum - Jammu Links News
What institutional investors are buying Reviva Pharmaceuticals Holdings Inc. stockOutstanding capital growth - Jammu Links News
What is Reviva Pharmaceuticals Holdings Inc. company’s growth strategyFree Buy/Sell Signal Notifications - Jammu Links News
Is it the right time to buy Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockInvest smarter with daily market updates - Jammu Links News
What drives Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock priceGet alerts on the hottest market movers - Jammu Links News
Published on: 2025-08-03 11:56:29 - Jammu Links News
How does Reviva Pharmaceuticals Holdings Inc. compare to its industry peersSuperior stock selection - Jammu Links News
Should I hold or sell Reviva Pharmaceuticals Holdings Inc. stock in 2025Capitalize on fast-growing investment opportunities - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. a growth stock or a value stockHigh-performance investment picks - Jammu Links News
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant a growth stock or a value stockAccess daily stock market expert updates - jammulinksnews.com
Published on: 2025-08-03 01:32:47 - jammulinksnews.com
What are the technical indicators suggesting about Reviva Pharmaceuticals Holdings Inc.AI Powered Target Finder For Consistent Profits - Jammu Links News
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant Outperform Peers After Recent PullbackDaily Smart Money Movement Monitor Activated - beatles.ru
Published on: 2025-07-29 04:00:41 - metal.it
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs during market volatilityConservative Entry for High Return Setup Backed - metal.it
Why Reviva Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionLow Volatility Stable Growth Picks Rank High - metal.it
Is it the right time to buy Reviva Pharmaceuticals Holdings Inc. stockFinancial News Opportunities That Work - Jammu Links News
How does Reviva Pharmaceuticals Holdings Inc. Equity Warrant generate profit in a changing economyExplosive capital appreciation - Jammu Links News
New Product Launches: Will They Boost Reviva Pharmaceuticals Holdings Inc. Stock in 2025Proven Return Strategy Execution - metal.it
What is the risk reward ratio of investing in Reviva Pharmaceuticals Holdings Inc. stockDiscover the fastest growing stocks today - Jammu Links News
What are Reviva Pharmaceuticals Holdings Inc. Equity Warrant company’s key revenue driversMarket-crushing profits - Jammu Links News
How many analysts rate Reviva Pharmaceuticals Holdings Inc. Equity Warrant as a “Buy”Proven strategies for superior portfolio growth - Jammu Links News
Published on: 2025-07-28 02:35:06 - jammulinksnews.com
Why is Reviva Pharmaceuticals Holdings Inc. stock attracting strong analyst attentionExceptional return forecasts - jammulinksnews.com
What makes Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock price move sharplyStrategic High Profit Opportunities - Newser
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
3.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):